{"version":"1.0","provider_name":"Practice Resource Centre","provider_url":"https:\/\/www.cosprc.ca\/fr\/","author_name":"Fetun Delessa","author_url":"https:\/\/www.cosprc.ca\/fr\/author\/rs9ebny670cpwyyn\/","title":"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19 - Practice Resource Centre","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"NSXcU6bKld\"><a href=\"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/\">Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/embed\/#?secret=NSXcU6bKld\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19\u00a0\u00bb &#8212; Practice Resource Centre\" data-secret=\"NSXcU6bKld\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"4&nbsp;avril&nbsp;2020 Alors que le virus de la COVID-19 devient rapidement la grande crise de sant\u00e9 publique de notre g\u00e9n\u00e9ration et que les cliniques externes r\u00e9duisent leurs horaires de consultation dans l\u2019espoir de r\u00e9duire la transmission de la maladie aux personnes vuln\u00e9rables, les ophtalmologistes doivent relever le d\u00e9fi de r\u00e9duire consid\u00e9rablement l\u2019utilisation des m\u00e9dicaments anti-VEGF, m\u00eame [&hellip;]","thumbnail_url":"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/image-9.png"}